Biogen

In News

An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows - AP News

AP News - Jul 14, 2026

What a new Alzheimer’s drug could mean for the future of treatment - The Boston Globe

The Boston Globe - Jul 17, 2026

Amylyx nears pivotal endocrine drug study readout - STAT

STAT - Jul 16, 2026

Exclusive: Genetic medicine startup launches to speed programs that stalled at Editas, Biogen - Endpoints News

Endpoints News - Jul 14, 2026

Biogen defends anti-tau drug after stock slides on Alzheimer’s readout - Fierce Biotech

Fierce Biotech - Jul 14, 2026

Biogen Taps Biopharmaceutical Veteran as Chief Legal Officer - Bloomberg Law News

Bloomberg Law News - Jul 16, 2026

Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch

MarketWatch - Jul 16, 2026

How Investors Are Reacting To Biogen (BIIB) At-Home LEQEMBI Autoinjector Approval - Yahoo Finance

Yahoo Finance - Jul 14, 2026

Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs - BioPharma Dive

BioPharma Dive - Jul 14, 2026

Biogen's Alzheimer's drug lowers toxic protein, but results were mixed - Reuters

Reuters - Jul 14, 2026

Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease - Biogen

Biogen - Jul 14, 2026

Weekly Rundown: Biogen pushes anti-tau drug into Phase 3 after endpoint miss - Drug Discovery News

Drug Discovery News - Jul 17, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment